Estimating and visualising the trade-off between benefits and harms on multiple clinical outcomes in network meta-analysis

Table 1 Probabilities of response to treament, remission, dropout due to any cause, and dropout due to side effects, estimated from the network of 18 antidepressants for the acute treatment of adults with major depressive disorder

	Response	Remission	Dropout for any cause	Dropout for side effects
Agomelatine	0.613	0.362	0.208	0.054
Amitriptyline	0.621	0.381	0.268	0.120
Bupropion	0.645	0.459	0.249	0.095
Citalopram	0.583	0.333	0.228	0.074
Clomipramine	0.569	0.378	0.315	0.171
Duloxetine	0.601	0.383	0.295	0.150
Escitalopram	0.638	0.393	0.212	0.066
Fluoxetine	0.569	0.347	0.236	0.078
Fluvoxamine	0.569	0.365	0.276	0.098
Milnacipran	0.596	0.352	0.249	0.070
Mirtazapine	0.629	0.371	0.246	0.096
Nefazodone	0.579	0.342	0.273	0.117
Paroxetine	0.611	0.375	0.244	0.092
Reboxetine	0.524	0.295	0.329	0.162
Sertraline	0.596	0.357	0.234	0.067
Trazodone	0.540	0.340	0.278	0.109
Venlafaxine	0.610	0.377	0.262	0.124
Vortioxetine	0.682	0.413	0.176	0.062

ISSN: 2046-4053